|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 329.9 GBX | +0.40% |
|
-1.35% | +2.56% |
| May. 03 | GSK plc : Back on track |  |
| May. 02 | Deutsche Bank likes TP ICAP but says sell CMC | AN |
(Reuters) - Consumer healthcare firm Haleon said on Wednesday that Dawn Allen has been appointed as its new chief financial officer, effective Nov. 1.
Allen, currently CFO at British food ingredients maker Tate & Lyle, replaces Tobias Hestler, who has informed the Haleon board that he will step down as CFO.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Savio D'Souza)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 655 GBX | -0.08% | +3.31% | 3.27B | ||
| 329.9 GBX | +0.40% | -1.35% | 37.81B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +2.56% | 37.81B | |
| +26.08% | 662B | |
| +22.59% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 289B | |
| +13.68% | 234B | |
| +4.12% | 198B | |
| -11.00% | 194B | |
| +8.08% | 167B |
HALEON PLC 
